{"ModuleTitle": "Company Description", "CompanyName": "Mirati Therapeutics, Inc.", "Symbol": "MRTX", "Address": "9393 TOWNE CENTRE DRIVE SUITE 200, SAN DIEGO, California, 92121, United States of America", "Phone": "858-332-3410", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "Mirati Therapeutics, Inc. is a clinical-stage oncology company developing\r\nproduct candidates to address the genetic and immunological promoters of cancer.\r\nIn immuno-oncology, we are advancing our kinase inhibitor clinical program where\r\nour product candidate has the potential to improve the immune environment of\r\ntumor cells and enhance and expand the efficacy of existing cancer immunotherapy\r\nmedicines when given in combination. Our KRAS inhibitor program is focused on\r\ndeveloping novel inhibitors of KRAS mutations and includes one clinical program\r\nand a preclinical program. We also have additional preclinical programs which\r\ninclude potentially first-in-class and best-in-class product candidates\r\nspecifically designed to address mutations and tumors where few treatment\r\noptions exist.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f26%2f0001628280-20-002301.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Charles M. Baum", "title": "President, Chief Executive Officer & Director"}, {"name": "Daniel R. Faga", "title": "Executive VP, Chief Operating & Financial Officer"}, {"name": "James G. Christensen", "title": "Chief Scientific Officer & Executive VP"}, {"name": "Joseph A. Leveque", "title": "Chief Medical Officer"}, {"name": "Philip Roberts", "title": "Senior Vice President-Technical Operations"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}